Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Dr Lal PathLabs

Explore full profile

The largest and most respected diagnostic service provider in India

IndiaFounded 1949Health Tech & Medtech
Valuation $2.5–5B Last recorded · 2026
Revenue $100–500M Latest reported FY
Headcount 5–10k Current team size
Total funding $10–50M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Dr Lal PathLabs and the history behind them.

About Dr Lal PathLabs

The story of Dr Lal PathLabs begins in 1949, a time of significant change in India. Dr. S.K. Lal, a pathologist trained in the British Indian Army, established a single pathology laboratory and blood bank in Delhi. He had a vision to provide authentic and reliable diagnostic services, a novel concept for a private enterprise at the time. The early years were focused on building a reputation for quality. A major turning point came in 1995 when the sole proprietorship was incorporated into a private limited company, setting the stage for structured growth. This was followed by a concerted effort to gain national and international accreditations in the early 2000s, solidifying its commitment to quality. In 2005, the company secured its first institutional investment from WestBridge Capital, which fueled a period of significant expansion, including strategic acquisitions. This growth trajectory continued, and in 2015, Dr Lal PathLabs launched its Initial Public Offering (IPO), getting listed on both the BSE and NSE. This event marked a new chapter for the company, providing capital for further nationwide expansion. Today, Dr Lal PathLabs operates a vast network of laboratories and patient service centers across India. The business functions on a hub-and-spoke model, with central reference labs supporting a wider network of regional and satellite centers to ensure efficiency and accessibility. Through strategic growth and a foundational commitment to quality, a single lab has transformed into a leading player in the Indian diagnostic landscape.

Source: Dealroom company data

At a glance

Status
Operational
Founded
1949
Headquarters
India
Employees
7,430
Open positions
20
Dealroom signal
55.6/100
Industry
Health
Sub-industry
Health Platform
Sector
Health Tech & Medtech, Diabetes, Performance Management, Oncology, Patient Care, Pay Per Result
Client focus
b2b
Investment activity
2 companies, latest Nov 2022
Capital deployed
—
Preferred round
SEED

Funding history

2 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
Other✓Other financing Dec 2015 $29M — JP Morgan · Reliance Capital · Fidelity Investments · State Bank of India —
SEED✓Equity / VC Aug 2010 $0 — TA Associates —
Showing the latest 2 of 2 recorded eventsBook a demo for the full funding history →

Financials

Revenue, earnings and profit over time

Revenue, earnings and other financial measures where available. Years marked “E” are estimates.

Company filings, research estimates and Dealroom dataBook a demo for the full financial model →

Growth signals

Dr Lal PathLabs website traffic

Latest recorded traffic for Dr Lal PathLabs is 2.2M monthly website visits, up 100% over the last three months. Dr Lal PathLabs's team grew 81.3% over the past year.

Latest monthly visits2.2M 3-month web change+100% 1-year team growth+81.3%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

CompanyHeadquartersStatusEmployeesTotal fundingValuation
Datos HealthDatos is a provider of a hospital-grade oncology patient management platform designed to connect the medical source of care directly with the patient for improved quality of life New York City, United States Operational 38 $7M $28M
PodimetricsDevelops an early warning system to predict and prevent diabetic foot ulcers Somerville, United States Operational
Merck & Co.Merck develops and produces medicines, vaccines, biologic therapies and animal health products Kenilworth, United States Operational
MedivizorMedivizor (medivizor.com) seeks to improve the quality of lives of those facing serious or chronic medical conditions Ramat Gan, Israel Operational
HumaProvides a digital health platform used for predictive care and research London, United Kingdom Operational
Among DoctorsAn integrated and innovative digital service, enabling the professional development of doctors globally Municipality of Kifisia, Greece Operational
TreatoIdentifies, aggregates and analyzes user-generated content from across the social health Web, to generate "patient voice"​ insights that help drive health-related decisions for patients and providers alike Yehud Monosson, Israel Operational
Health CatalystTech platform that organizes and links health-related data from different systems and makes it available for all users South Jordan, United States Operational
Showing 8 of the closest matchesCompare every metric →

Investors

7 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed1 investor entered at this stage

  • TA Associates

Other known investors6 additional known investors

Team profiled 25 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 7 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
12 countries with
team presence
🇮🇳 India97.9%
🇳🇵 Nepal0.5%
🇧🇩 Bangladesh0.3%
🇨🇦 Canada0.2%
🇦🇪 United Arab Emirates0.2%
Top 5 of 12 shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Dr Lal PathLabs on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Dr Lal PathLabs’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.